The Brink's Company (BCO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
20 Mar, 2026Executive summary
The annual meeting is scheduled for April 28, 2026, with shareholders voting on director elections, executive compensation, auditor ratification, an amended equity plan, and a shareholder proposal.
2025 financial highlights include $5.3B revenue (+5%), $977M adjusted EBITDA (+7%), $710M non-GAAP operating profit (+13%), and $436M free cash flow (+9%).
AMS/DRS revenue grew 21% to $1.5B, reflecting strategic focus on digital and managed services.
Voting matters and shareholder proposals
Shareholders will vote on nine director nominees, a non-binding say-on-pay resolution, auditor ratification, approval of the amended 2024 Equity Incentive Plan, and a shareholder proposal on reporting employee retention rates by demographic categories.
The board recommends voting FOR all management proposals and AGAINST the shareholder proposal.
Board of directors and corporate governance
Eight of nine director nominees are independent; average tenure is 8.8 years.
Board committees (Audit, Compensation, Governance, Finance) are composed entirely of independent directors.
Annual board, committee, and individual evaluations are conducted, with periodic use of external facilitators.
Directors are subject to a mandatory retirement age and overboarding policy.
Proxy access rights are available for shareholders owning at least 20% of shares.
Latest events from The Brink's Company
- $6.6B merger forms a global fintech leader with $200M synergies and expanded reach.BCO
M&A announcement27 Feb 2026 - $6.6B deal forms a $10B revenue fintech leader with $200M synergies and record cash flow.BCO
Q4 202526 Feb 2026 - Record Q2 revenue, margin expansion, and strong AMS/DRS growth drive positive 2024 outlook.BCO
Q2 20242 Feb 2026 - AMS/DRS growth outpaced expectations, but FX and security losses pressured Q3 profits.BCO
Q3 202416 Jan 2026 - AMS/DRS drove 12% organic growth, margin expansion, and strong cash flow in 2024.BCO
Q4 202417 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, with focus on governance and ESG.BCO
Proxy Filing1 Dec 2025 - Q2 2025 saw record margins, 5% organic growth, and $130M in share repurchases.BCO
Q2 202523 Nov 2025 - Q1 2025 saw 6% organic growth, margin gains, and accelerated share repurchases.BCO
Q1 202521 Nov 2025 - Q3 2025 saw record margins, 6% revenue growth, and strong AMS/DRS expansion.BCO
Q3 20256 Nov 2025